ProQR Therapeutics N.V. | Ownership
Companies that own ProQR Therapeutics N.V.
Jennison Associates LLC
2,981,205
9.34%
30,831
0.02%
06/30/2018
Adage Capital Management LP
2,162,527
6.77%
662,527
0.04%
06/30/2018
Invus Public Equities Advisors LLC
1,500,000
4.7%
-400,000
0.39%
06/30/2018
OrbiMed Advisors LLC
1,302,955
4.08%
0
0.1%
06/30/2018
Sphera Funds Management Ltd.
493,749
1.55%
-164,751
0.55%
06/30/2018
ClearBridge Investments LLC
492,567
1.54%
-6,706
0%
06/30/2018
De Grote Voskuil Capital BV
300,000
0.94%
300,000
1.26%
12/31/2016
Morgan Stanley & Co. LLC
289,875
0.91%
60,575
0%
06/30/2018
Pura Vida Investments LLC
271,159
0.85%
271,159
1.63%
06/30/2018
Fidelity Management & Research Co.
237,916
0.75%
0
0%
06/30/2018
| Address |
Zernikedreef 9
Leiden Zuid-Holland 2333 CK
Netherlands
|
|
Employees
|
- |
| Website |
http://www.proqr.com |
| Updated |
07/08/2019 |
| ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands. |
